Medley Management Inc.
MDLM
$0.00
$0.000.00%
| Weiss Ratings | MDLM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | MDLM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | MDLM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 601.54 | |||
| Price History | MDLM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -99.50% | |||
| 3-Year Total Return | -99.99% | |||
| 5-Year Total Return | -100.00% | |||
| 52-Week High % Change | -99.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | MDLM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Jun 12, 2024 | |||
| 52-Week High Price (Date) | Nov 18, 2024 | |||
| Valuation | MDLM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.00 | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -4.32 | |||
| Earnings Per Share Growth | -24.94% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MDLM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 678.30K | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $0.30 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $0.30 | |||
| Company Info | MDLM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 212-759-0777 | |||
| Address | 280 Park Avenue New York, NY 10017 | |||
| Website | www.mdly.com | |||
| Country | United States | |||
| Year Founded | 2014 | |||
| Profitability | MDLM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 5.87% | |||
| Profit Margin | -8.01% | |||
| Management Effectiveness | MDLM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.89% | |||
| Return on Equity | -- | |||
| Income Statement | MDLM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 26.14M | |||
| Total Revenue (TTM) | 33.25M | |||
| Revenue Per Share | $49.02 | |||
| Gross Profit (TTM) | 13.69M | |||
| EBITDA (TTM) | 2.67M | |||
| EBIT (TTM) | 1.95M | |||
| Net Income (TTM) | -2.66M | |||
| Net Income Avl. to Common (TTM) | -2.66M | |||
| Total Revenue Growth (Q YOY) | -20.43% | |||
| Earnings Growth (Q YOY) | 79.82% | |||
| EPS Diluted (TTM) | -4.32 | |||
| EPS Diluted Growth (Q YOY) | 80.76% | |||
| Balance Sheet | MDLM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.86M | |||
| Cash Per Share (Q) | $5.69 | |||
| Total Current Assets (Q) | 18.74M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -133.67M | |||
| Current Ratio (Q) | 0.736 | |||
| Book Value Per Share (Q) | -$11.17 | |||
| Total Assets (Q) | 35.55M | |||
| Total Current Liabilities (Q) | 25.47M | |||
| Total Debt (Q) | 135.17M | |||
| Total Liabilities (Q) | 169.22M | |||
| Total Common Equity (Q) | -7.74M | |||
| Cash Flow | MDLM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -460.00K | |||
| Cash from Financing (TTM) | -3.06M | |||
| Net Change in Cash (TTM) | -6.70M | |||
| Levered Free Cash Flow (TTM) | -219.70K | |||
| Cash from Operations (TTM) | -3.18M | |||
